Published 13 March 2006. doi:10.1083/jcb.200601114
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 172, Number 6, 795-797
Skeletons in the p53 tumor suppressor closet: genetic evidence that p53 blocks bone differentiation and development
Gerard P. Zambetti1,
Edwin M. Horwitz2, and
Ernestina Schipani3
1 Department of Biochemistry and 2 Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105
3 Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114
Correspondence to Gerard P. Zambetti: gerard.zambetti{at}stjude.org
Abstract
A series of in vitro tissue culture studies indicated that the p53 tumor suppressor promotes cellular differentiation, which could explain its role in preventing cancer. Quite surprisingly, however, two new in vivo studies (Lengner et al., 2006; Wang et al., 2006) provide genetic evidence that p53 blocks osteoblast differentiation and bone development. These interesting results and their biological and clinical implications are the focus of this comment.
Abbreviations used in this paper: MCSF, macrophage colonystimulating factor; RANKL, receptor activator of nuclear factor
B ligand.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Wang, X., Goh, C. H., Li, B.
(2007). p38 Mitogen-Activated Protein Kinase Regulates Osteoblast Differentiation through Osterix. Endocrinology
148: 1629-1637
[Abstract]
[Full Text]